loadpatents
Patent applications and USPTO patent grants for Arisan Therapeutics Inc..The latest application filed is for "heterocyclic compounds for the treatment of arenavirus infection".
Patent | Date |
---|---|
Heterocyclic Compounds For The Treatment Of Arenavirus Infection App 20220281825 - McCormack; Kenneth ;   et al. | 2022-09-08 |
Compounds For The Treatment Of Arenavirus Infection App 20220193038 - Brown; Eric ;   et al. | 2022-06-23 |
Heterocyclic compounds for the treatment of arenavirus Grant 11,352,328 - Plewe , et al. June 7, 2 | 2022-06-07 |
Enantiomerically Pure Adamantane Carboxamides For The Treatment Of Filovirus Infection App 20210171521 - Plewe; Michael Bruno ;   et al. | 2021-06-10 |
Heterocyclic Compounds for the Treatment of Arenavirus App 20190308938 - McCormack; Kenneth ;   et al. | 2019-10-10 |
NCAGE Code | 616D2 | ARISAN THERAPEUTICS, INC. |
CAGE Code | 616D2 | ARISAN THERAPEUTICS, INC. |
S.A.M. Registration | 616D2 [962535782] | ARISAN THERAPEUTICS, INC. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.